多治疗临床试验中析因设计与多臂多阶段设计的比较
该研究比较了多臂多阶段设计与析因设计(重点为2×2析因设计,患者接受治疗A、B、两者或均不接受)在不同情景下的性能与特征,采用理论与模拟方法,并附一项骨关节炎临床试验案例。研究发现,在最小化临界值的最优析因设计中,分配比与均衡设计差异很大;析因设计在假设中度偏离时把握度可能大幅损失,而假设成立时相较多次多阶段设计获益甚微。
要点
- 2×2析因设计下构建适当检验统计量可在整体控制I类错误下检验各治疗与对照的效应。
- 最优析因设计的分配比与均衡设计差异很大,影响临界值与目标把握度所需样本量。
- 析因设计在假设中度偏离时把握度可能大幅损失,假设成立时相较多次多阶段设计获益甚微。
核心结论
- 在最小化相关临界值的最优析因设计中,相应分配比与均衡设计差异很大。
- 析因设计在假设中度偏离时存在把握度可能大幅损失的证据,而假设成立时相较多次多阶段设计获益甚微。
研究设计与样本
- 研究比较多臂多阶段设计与析因设计,特别考虑2×2析因设计,患者分组接受治疗A、B、两者或均不接受。
- 在不同情景下通过理论与模拟研究两类设计的性能与特征,并附一项骨关节炎临床试验案例研究。
主要发现
- 对析因设计构建适当检验统计量,可在整体控制I类错误下检验与对照相比无治疗效应的假设。
- 研究了分配比选择对临界值和目标把握度所需样本量的影响。
- 研究了治疗A与B之间交互作用可能性对检验各治疗效应显著性时I类和II类错误的影响。
- 最优析因设计的分配比与均衡设计差异很大。
- 析因设计在假设中度偏离时存在把握度可能大幅损失的证据,假设成立时相较多次多阶段设计获益甚微。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
When several treatments are available for evaluation in a clinical trial, different design options are available. We compare multi-arm multi-stage with factorial designs, and in particular, we will consider a 2 × 2 factorial design, where groups of patients will either take treatments A, B, both or neither. We investigate the performance and characteristics of both types of designs under different scenarios and compare them using both theory and simulations. For the factorial designs, we construct appropriate test statistics to test the hypothesis of no treatment effect against the control group with overall control of the type I error. We study the effect of the choice of the allocation ratios on the critical value and sample size requirements for a target power. We also study how the possibility of an interaction between the two treatments A and B affects type I and type II errors when testing for significance of each of the treatment effects. We present both simulation results and a case study on an osteoarthritis clinical trial. We discover that in an optimal factorial design in terms of minimising the associated critical value, the corresponding allocation ratios differ substantially to those of a balanced design. We also find evidence of potentially big losses in power in factorial designs for moderate deviations from the study design assumptions and little gain compared with multi-arm multi-stage designs when the assumptions hold. © 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd.
引用
- Jaki T, Vasileiou D. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments. Stat Med. 2016. PMID: 27804166. doi:10.1002/sim.7159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。